期刊文献+

解脲支原体不同生物群别对小鼠体外受精的影响 被引量:5

Impact of Different Biovar of Ureaplasma Urealyticum on in vitro Fertilization in Mice
下载PDF
导出
摘要 目的:观察不同生物型别的解脲支原体(UU)对小鼠体外受精的影响,以探讨其对体外受精致病性的差异。方法:用血清型3型UU代表含有较小基因的生物群1(或Parvo生物型),血清型8型UU代表含有较大基因的生物群2(或T960生物型)。取小鼠成熟卵丘-卵母细胞复合体随机分为实验组与对照组,在体外加入小鼠精子进行受精。对照组精卵在不含UU的HTF培养液中培养,实验组精卵分别在含102~105CCU/ml的8型UU、103~106CCU/ml的3型UUHTF培养液中培养48h。每24h在倒置显微镜下观察记录,通过统计各组的受精率、D2评分、4-细胞期胚胎形成率,评价受精及胚胎发育情况。以观察不同生物群UU对小鼠成熟卵子体外受精的影响。结果:3型UU浓度≤103CCU/ml、8型UU浓度≤102CCU/ml时,受精率、D2评分、4-细胞期胚胎形成率等胚胎发育指标与对照组比较差异均无统计学意义(P>0.05);3型UU浓度≥105CCU/ml、8型UU浓度≥104CCU/ml时,受精率、D2评分、4-细胞期胚胎形成率均较对照组低,且差异有统计学意义(P(0.01);而当3型UU浓度为104CCU/ml、8型UU浓度为103CCU/ml时,受精率与对照组比较差异无统计学意义。结论:UU能够干扰小鼠的体外受精,3型UU≥104CCU/ml、8型UU≥103CCU/ml浓度时就可对小鼠的体外受精造成抑制作用。代表生物群2的血清型8型UU可能较代表生物群1的血清型3型UU具有更强的致病性。 Objective: To observe the impact of different biovars of ureaplasma urealyticum (UU) on in vitro fertilization (IVF) in mice in order to investigate the pathogenic effects of UU in IVF treatment. Methods: The UU serotype 3 was selected to represent biovar 1 (Parvo biotype), and the UU serotype 8 to represent biovar 2 (T960 biotype). The cumulus oocyte complexes (COCS) of the mice were divided randomly into the control and treatment groups. The mouse sperms were added into each group for in vitro fertilization treatment. In the control group 1 and 6, the COCS and the sperms were cultured in the human tubal fluid (HTF) media without UU. In the treatment group 2, 3, 4 and 5, the COCS and the sperms were cultured in the HTF media with 10^2 - 10^5 CCU/ml of the UU serotype 8. In the treatment group 7, 8, 9 and 10, the COCS and the sperms were cultured in the HTF media with 10^3 - 10^6 CCU/ml of the UU serotype 3. The COCS and the sperms were cultured at 37℃ under 5% CO2 in a sealed culture chamber. After 48h incubation, the fertilization rate, the embryo quality score of day 2, the rate of embryogenesis at the 4 - cell stage were observed every 24h under a Nikon inverted microscope. Results: There were no significant differences in the fertilization rate, the embryo quality score of day 2, and the rate of embryogenesis at the 4 - cell stage between the treatment group and the control group when the media contained not more than 10^3 CCU/ml of the UU serotype 3 or not more than 10^2 CCU/ml of the UU serotype 8 (P 〉 0.05). The fertilization rate, the embryo quality score of day 2, and the rate of embryogenesis at the 4 - cell stage in the treatment group were lower than those in the control group when the media contained not less than 10^5 CCU/ml of the UU serotype 3 or not less than 10^4 CCU/ml of the UU serotype 8, showing the significant differences ( P 〈 0.01 ). There were no significant differences in the fertilization rate between the treatment group and the control group when the media contained 10^4 CCU/ml of the UU serotype 3 or 10^3 CCU/ml of the UU serotype 8. Conclusion: The UU can interfere with the IVF treatment in mice. The IVF treatment could be inhibited in mice when the concentration of UU serotype 3 is not less than 10^4 CCU/ml or UU serotype 8 not less than 10^3 CCU/ ml. Compared with the UU serotype 3 which represents biovar 1 (Parvo biotype), the UU serotype 8 which represents biovar 2 ( T960 biotype) may have more powerful pathogenic effects.
出处 《中国计划生育学杂志》 北大核心 2010年第2期82-85,共4页 Chinese Journal of Family Planning
基金 浙江省医药卫生科学研究基金项目(项目编号:2007A200)
关键词 解脲支原体 小鼠 体外受精 生物群 Ureaplasma urealyticum Mouse in vitro fertilization Biovar
  • 相关文献

参考文献14

二级参考文献27

  • 1汪宁,赵季文,徐萃瑜,贺晓新,林舜华,方海林,姚航平.不同人群生殖泌尿道解脲支原体1~14血清型感染状态的研究[J].中华流行病学杂志,1995,16(4):207-210. 被引量:32
  • 2史同新,刘立倩,管淑梅,徐敬星.解脲脲原体在孕妇与新生儿泌尿生殖道之间的传播[J].中华皮肤科杂志,2007,40(5):299-299. 被引量:5
  • 3孔繁荣,中华流行病学杂志,1995年,16卷,42页
  • 4阎国富,国外医学.皮肤性病学分册,1994年,20卷,199页
  • 5团体著者,性病防治手册(第2版),1994年,45页
  • 6Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas[J]. Microbiol Mol Biol Rev,1998,62(4):1094-1156.
  • 7Kong F, Ma Z, James G, et al, Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays[J]. J Clin Microbiol, 2000, 38 (3) :1175-1179.
  • 8Harasawa R, Kanamoto Y. Differentiation of two biovars of Ureaplasma urealyticum based on the 16S-23S rRNA intergenic spacer region[J]. J Clin Microbiol,1999, 37(12) :4135-4138.
  • 9Glass JI, Lefkowitz EJ, Glass JS, et al. The complete sequence of the mucosal pathogen Ureaplasma urealyticum [J].Nature,2000, 407(6805):757-762.
  • 10Pitcher D, Sillis M, Robertson JA. Simple method for determining biovar and serovar types of Ureaplasma urealyticum clinical isolates using PCR single-strand conformation polymorphism analysis[J]. J Clin Microbiol, 2001,39 (5): 1840-1844.

共引文献91

同被引文献29

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部